110 related articles for article (PubMed ID: 16110692)
1. Anti-diuretic for operational aircrew: effects of desmopressin on urine flow, cognition, and sleepiness.
Nicholson AN; Turner C
Aviat Space Environ Med; 2005 Aug; 76(8):760-5. PubMed ID: 16110692
[TBL] [Abstract][Full Text] [Related]
2. Central effects of cinnarizine: restricted use in aircrew.
Nicholson AN; Stone BM; Turner C; Mills SL
Aviat Space Environ Med; 2002 Jun; 73(6):570-4. PubMed ID: 12056673
[TBL] [Abstract][Full Text] [Related]
3. Antihistamines and aircrew: usefulness of fexofenadine.
Nicholson AN; Stone BM; Turner C; Mills SL
Aviat Space Environ Med; 2000 Jan; 71(1):2-6. PubMed ID: 10632124
[TBL] [Abstract][Full Text] [Related]
4. Desmopressin, as a "designer-drug," in the treatment of overactive bladder syndrome.
Hashim H; Malmberg L; Graugaard-Jensen C; Abrams P
Neurourol Urodyn; 2009; 28(1):40-6. PubMed ID: 18726947
[TBL] [Abstract][Full Text] [Related]
5. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study.
van Kerrebroeck P; Rezapour M; Cortesse A; Thüroff J; Riis A; Nørgaard JP
Eur Urol; 2007 Jul; 52(1):221-9. PubMed ID: 17280773
[TBL] [Abstract][Full Text] [Related]
6. Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray.
De Guchtenaere A; Raes A; Vande Walle C; Hoebeke P; Van Laecke E; Donckerwolcke R; Vande Walle J
J Urol; 2009 Jan; 181(1):302-9; discussion 309. PubMed ID: 19013601
[TBL] [Abstract][Full Text] [Related]
7. Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin.
Fu FG; Lavery HJ; Wu DL
Neurourol Urodyn; 2011 Mar; 30(3):312-6. PubMed ID: 21305590
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive therapy in critical occupations: studies with an angiotensin II antagonist.
Nicholson AN; Roberts DP; Stone BM; Turner C
Aviat Space Environ Med; 2001 Dec; 72(12):1096-101. PubMed ID: 11763110
[TBL] [Abstract][Full Text] [Related]
9. Central effects of the H1-antihistamine, cetirizine.
Nicholson AN; Turner C
Aviat Space Environ Med; 1998 Feb; 69(2):166-71. PubMed ID: 9491258
[TBL] [Abstract][Full Text] [Related]
10. Indirect-response modeling of desmopressin at different levels of hydration.
Callréus T; Odeberg J; Lundin S; Höglund P
J Pharmacokinet Biopharm; 1999 Oct; 27(5):513-29. PubMed ID: 10948696
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis.
Bosma R; Wynia K; Havlíková E; De Keyser J; Middel B
Acta Neurol Scand; 2005 Jul; 112(1):1-5. PubMed ID: 15932348
[TBL] [Abstract][Full Text] [Related]
12. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning.
De Guchtenaere A; Vande Walle C; Van Sintjan P; Donckerwolcke R; Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle J
J Urol; 2007 Dec; 178(6):2635-9; discussion 2639. PubMed ID: 17945291
[TBL] [Abstract][Full Text] [Related]
13. Benzodiazepine-induced reduction in activity mirrors decrements in cognitive and psychomotor performance.
Dawson J; Boyle J; Stanley N; Johnsen S; Hindmarch I; Skene DJ
Hum Psychopharmacol; 2008 Oct; 23(7):605-13. PubMed ID: 18570226
[TBL] [Abstract][Full Text] [Related]
14. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
Johnson MW; Suess PE; Griffiths RR
Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomography.
Anderer P; Saletu B; Wolzt M; Culic S; Assandri A; Nannipieri F; Rosini S; Saletu-Zyhlarz GM
Hum Psychopharmacol; 2008 Apr; 23(3):243-54. PubMed ID: 18181252
[TBL] [Abstract][Full Text] [Related]
16. Effects of levetiracetam on nocturnal sleep and daytime vigilance in healthy volunteers.
Cicolin A; Magliola U; Giordano A; Terreni A; Bucca C; Mutani R
Epilepsia; 2006 Jan; 47(1):82-5. PubMed ID: 16417535
[TBL] [Abstract][Full Text] [Related]
17. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
Farber RH; Burke PJ
Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
[TBL] [Abstract][Full Text] [Related]
18. The relationship between the action of arginine vasopressin and responsiveness to oral desmopressin in older men: a pilot study.
Johnson TM; Burridge A; Issa MM; Miller M; Tang T; Ouslander JG
J Am Geriatr Soc; 2007 Apr; 55(4):562-9. PubMed ID: 17397435
[TBL] [Abstract][Full Text] [Related]
19. Motion-sickness medications for aircrew: impact on psychomotor performance.
Paul MA; MacLellan M; Gray G
Aviat Space Environ Med; 2005 Jun; 76(6):560-5. PubMed ID: 15945400
[TBL] [Abstract][Full Text] [Related]
20. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis.
Vande Walle JG; Bogaert GA; Mattsson S; Schurmans T; Hoebeke P; Deboe V; Norgaard JP;
BJU Int; 2006 Mar; 97(3):603-9. PubMed ID: 16469035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
